pharma · Heart Failure · Atrial Fibrillation · RYTM
Rhythm Pharmaceuticals Netherlands
Rhythm Pharmaceuticals Netherlands B.V.
Matisse Pharmaceuticals is a pharma organization headquartered in geleen, NL. It trades on NYSE under ticker RYTM. Primary therapeutic focus areas include Heart Failure, Atrial Fibrillation, Hypothalamic Obesity, Paroxys
BRIGHTLANDS CHEMELOT CAMPUS, VAN ITERSON BUILDING, BURGEMEESTER LEMMENSSTRAAT 352, Geleen, nl HQ
2014 Founded
10 Employees
Public company Type
RYTM · NYSE Ticker
Company details
- Status
- Public
- HQ
- BRIGHTLANDS CHEMELOT CAMPUS, VAN ITERSON BUILDING, BURGEMEESTER LEMMENSSTRAAT 352, Geleen, nl
- Founded
- 2014
- Employees
- 10
- Programs
- 73
- Drugs
- 38
- Patents
- 12
Freezor® Cardiac Cryoablation Catheter CryoConsole System
Approved · other · Tachycardia, Atrioventricular Nodal Reentry
Freezor® Cardiac Cryoablation Catheter CryoConsole System for Tachycardia, Atrioventricular Nodal Reentry is a Approved program (other) at Rhythm Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Internal code PS-010
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Rhythm Pharmaceuticals Netherlands B.V.
- Phase
- Approved
- Modality
- other
- Indication
- Tachycardia, Atrioventricular Nodal Reentry
- Status
- completed
- Trials
- 1